Allgemein

Partnership combines deep patient safety and risk management capabilities with MIDAS+ expertise ATLANTA–(BUSINESS WIRE)–Riskonnect, the leading integrated risk management software solution provider serving 1200 hospitals and thousands of other healthcare organizations, has partnered with MG Select, a professional services and strategic advisory firm, to assist companies transitioning away from legacy software platform MIDAS+. “Riskonnect has … [Read more…]

Gelest exclusive supplier of chemistry for OcuMedic proprietary drug eluting contact lens and corneal bandage MULLICA HILL, N.J.–(BUSINESS WIRE)–#Cornea—OcuMedic, Inc., the developer of new proprietary, drug-eluting soft contact lens/clear corneal bandage technology to replace eye drops, today announced it has entered into an exclusive supply agreement and received a strategic investment from Gelest, Inc., a … [Read more…]

Survey shows lack of rural broadband access equates to lack of access to health insurance and necessary medical care FERGUS FALLS, Minn.–(BUSINESS WIRE)–Communicating for America (CA), a rural advocacy organization, has released a new study that correlates the lack of high-speed internet to the lack of health insurance coverage and access to health care. The … [Read more…]

– Intravitreal ANX007 was well-tolerated and demonstrated full target engagement and inhibition of C1q in the eye for at least four weeks – – Annexon plans to advance the clinical development of ANX007 in geographic atrophy – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Annexon Biosciences, a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) – Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering. The 3D bioprinting market is projected to reach USD 1,647 million by 2024 from USD … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Respiratory Syncytial Virus Attachment Glycoprotein – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report Respiratory Syncytial Virus Attachment Glycoprotein – Pipeline Review, H2 2019, outlays comprehensive information on the Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) targeted therapeutics, complete with analysis by indications, stage of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Physicians And Other Health Practitioners Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. The physicians and other health practitioners market consists of sales of physician and other health practitioners’ services and related goods by entities (organizations, sole traders and partnerships) that provide medical care services. This industry includes specialist … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Devices Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. The orthopedic devices (or) equipment market consists of sales of orthopedic devices and related services by entities (organizations, sole traders and partnerships) that produce orthopedic devices used in treating bone abnormalities. This industry includes establishments that produce devices used … [Read more…]

Ophthalmologist Jorn S. Jorgensen, CEO and Founder of EuroEyes, Implanted EVO ICLs in His Son, Jannik Jorgensen LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Dr. Jorn S. Jorgensen successfully implanted the Company’s EVO Visian ICL … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Neuronal Acetylcholine Receptor Subunit Alpha 7 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. The latest report Neuronal Acetylcholine … [Read more…]